Please use this identifier to cite or link to this item: https://doi.org/10.3390/ijms19082362
DC FieldValue
dc.titleMagnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer
dc.contributor.authorRanaware A.M.
dc.contributor.authorBanik K.
dc.contributor.authorDeshpande V.
dc.contributor.authorPadmavathi G.
dc.contributor.authorRoy N.K.
dc.contributor.authorSethi G.
dc.contributor.authorFan L.
dc.contributor.authorKumar A.P.
dc.contributor.authorKunnumakkara A.B.
dc.date.accessioned2019-03-11T02:20:46Z
dc.date.available2019-03-11T02:20:46Z
dc.date.issued2018
dc.identifier.citationRanaware A.M., Banik K., Deshpande V., Padmavathi G., Roy N.K., Sethi G., Fan L., Kumar A.P., Kunnumakkara A.B. (2018). Magnolol: A neolignan from the Magnolia family for the prevention and treatment of cancer. International Journal of Molecular Sciences 19 (8) : 2362. ScholarBank@NUS Repository. https://doi.org/10.3390/ijms19082362
dc.identifier.issn16616596
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/152149
dc.description.abstractThe past few decades have witnessed widespread research to challenge carcinogenesis; however, it remains one of the most important health concerns with the worst prognosis and diagnosis. Increasing lines of evidence clearly show that the rate of cancer incidence will increase in future and will create global havoc, designating it as an epidemic. Conventional chemotherapeutics and treatment with synthetic disciplines are often associated with adverse side effects and development of chemoresistance. Thus, discovering novel economic and patient friendly drugs that are safe and efficacious is warranted. Several natural compounds have proved their potential against this dreadful disease so far. Magnolol is a hydroxylated biphenyl isolated from the root and stem bark of Magnolia tree. Magnolol can efficiently prevent or inhibit the growth of various cancers originating from different organs such as brain, breast, cervical, colon, liver, lung, prostate, skin, etc. Considering these perspectives, the current review primarily focuses on the fascinating role of magnolol against various types of cancers, and the source and chemistry of magnolol and the molecular mechanism underlying the targets of magnolol are discussed. This review proposes magnolol as a suitable candidate that can be appropriately designed and established into a potent anti-cancer drug. © 2018 by the authors. Licensee MDPI, Basel, Switzerland.
dc.publisherMDPI AG
dc.sourceScopus
dc.subjectCancer
dc.subjectChemoresistance
dc.subjectMagnolol
dc.subjectMolecular targets
dc.subjectPhytochemicals
dc.typeReview
dc.contributor.departmentDEPT OF PHARMACOLOGY
dc.description.doi10.3390/ijms19082362
dc.description.sourcetitleInternational Journal of Molecular Sciences
dc.description.volume19
dc.description.issue8
dc.description.page2362
dc.published.statepublished
dc.grant.idIITB
dc.grant.idCity
dc.grant.idNUS
dc.grant.fundingagencyIndian Institute of Technology Bombay
dc.grant.fundingagencyCity, University of London
dc.grant.fundingagencyNational University of Singapore
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
ijms19082362.pdf1.2 MBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

53
checked on Jul 25, 2021

Page view(s)

202
checked on Jul 23, 2021

Download(s)

2
checked on Jul 23, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.